Browse > Article
http://dx.doi.org/10.5352/JLS.2020.30.4.379

Anti-lymphoma Activities of Phlojodicarpus sibiricus and Artemisia kruhsiana Besser Extracts  

Kim, Jisu (Department of Integrated Biological Science, College of Natural Science, Pusan National University)
Kim, Dong Uk (Department of Integrated Biological Science, College of Natural Science, Pusan National University)
Nam, Jehyun (Department of Integrated Biological Science, College of Natural Science, Pusan National University)
Jeon, Byeol Eun (Department of Integrated Biological Science, College of Natural Science, Pusan National University)
Okhlopkova, Zhanna M. (Department of Biology, North-Eastern Federal University)
Zulfugarov, Ismayil S. (Department of Biology, North-Eastern Federal University)
Kim, Sang-Woo (Department of Integrated Biological Science, College of Natural Science, Pusan National University)
Publication Information
Journal of Life Science / v.30, no.4, 2020 , pp. 379-385 More about this Journal
Abstract
Phlojodicarpus sibiricus and Artemisia kruhsiana Besser are medicinal plants traditionally used in Russia. Phlojodicarpus sibiricus extracts (PSE) have been shown to have anti-obesity properties, and Artemisia kruhsiana Besser extracts (AKBE) contain terpenoid compounds that exert various medicinal effects. Here, we investigated the potential pro-apoptotic effects of PSE and AKBE in diffuse large B-cell lymphoma (DLBCL) and elucidated the underlying mechanism. PSE and AKBE treatment of six DLBCL cell lines with various genetic abnormalities effectively reduced cell viability in a dose-dependent manner, while having a minimal impact on the survival of normal murine bone marrow cells and splenocytes. This suggests that the cytotoxic effects of PSE and AKBE are specific to DLBCL cells. Therefore, we expect limited side effects when these plant extracts are administered to DLBCL patients. Our JC-1 assays demonstrate that the pro-apoptotic effects of these plant extracts are produced by a reduction of anti-apoptotic Bcl-2 family members and, thereby, disruption of the mitochondrial membrane potential. Moreover, PSE and AKBE induce cell death independently of Myc, whose abnormalities are frequently observed in patients with DLBCL and are associated with poor prognosis. Our findings reveal hitherto uncharacterized pro-apoptotic effects of PSE and AKBE in DLBCL. Isolation of single compounds with anti-lymphoma activities should be pursued further.
Keywords
Artemisia kruhsiana Besser; apoptosis; cell survival; diffuse large B-cell lymphoma; Phlojodicarpus sibiricus;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T. and Yu, X. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503.   DOI
2 Blenk, S., Engelmann, J., Weniger, M., Schultz, J., Dittrich, M., Rosenwald, A., Muller-Hermelink, H. K., Muller, T. and Dandekar, T. 2007. Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform. 3, 117693510700300004.
3 Coiffier, B. 2007. Rituximab therapy in malignant lymphoma. Oncogene 26, 3603-3613.   DOI
4 Compagno, M., Lim, W. K., Grunn, A., Nandula, S. V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M. and Califano, A. 2009. Mutations of multiple genes cause deregulation of NF-${\kappa}B$ in diffuse large B-cell lymphoma. Nature 459, 717.   DOI
5 Fesik, S. W. and Shi, Y. 2001. Controlling the caspases. Science 294, 1477-1478.   DOI
6 Fulda, S. and Debatin, K. M. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798.   DOI
7 Gantimur, D. and Semenov, A. 1981. Coumarins fromPhlojodicarpus sibiricus. Chem. Nat. Compd. 17, 41-43.   DOI
8 Habermann, T. M., Weller, E. A., Morrison, V. A., Gascoyne, R. D., Cassileth, P. A., Cohn, J. B., Dakhil, S. R., Woda, B., Fisher, R. I. and Peterson, B. A. 2006. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J. Clin. Oncol. 24, 3121-3127.   DOI
9 Kumar, V., Abbas, A. K., Fausto, N. and Aster, J. C. 2014. Robbins and Cotran pathologic basis of disease, professional edition e-book, Elsevier health sciences.
10 Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Booth, C. J., Mehal, W. Z., Inayat, I. and Flavell, R. A. 2006. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311, 847-851.   DOI
11 Lenz, G. and Staudt, L. M. 2010. Aggressive lymphomas. N. Engl. J. Med. 362, 1417-1429.   DOI
12 Martinou, J. C. and Youle, R. J. 2011. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell 21, 92-101.   DOI
13 Project, N. H. s. L. C. 1997. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 89, 3909-3918.   DOI
14 Mazumder, S., Choudhary, G. S., Al-harbi, S. and Almasan, A. 2012. Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells. Cancer Res. 72, 3069-3079.   DOI
15 Nam, J., Kim, D. U., Kim, E., Kwak, B., Ko, M. J., Oh, A. Y., Park, B. J., Kim, Y. W., Kim, A. and Sun, H. 2019. Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival. Leukemia 33, 2912-2923.   DOI
16 Olennikov, D. N., Fedorov, I. A., Kashchenko, N. I., Chirikova, N. K. and Vennos, C. 2019. Khellactone derivatives and other phenolics of phlojodicarpus sibiricus (Apiaceae): HPLC-DAD-ESI-QQQ-MS/MS and HPLC-UV profile, and antiobesity potential of dihydrosamidin. Molecules 24, 2286.   DOI
17 Savage, K. J., Johnson, N. A., Ben-Neriah, S., Connors, J. M., Sehn, L. H., Farinha, P., Horsman, D. E. and Gascoyne, R. D. 2009. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 114, 3533-3537.
18 Tang, H. Q., Hu, J., Yang, L. and Tan, R. X. 2000. Terpenoids and flavonoids from Artemisia species. Planta Med. 66, 391-393.   DOI
19 Texas, B. R. I. o. 2008. Journal of the Botanical Research Institute of Texas, Botanical Research Institute of Texas.